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ABSTRACT
Purpose: To analyze the expression of metalloproteinase-1, metalloproteinase-7 and vascular endothelial growth factor (VEGF) in
colorectal adenocarcinoma, and to correlate these with the clinical-pathological prognostic factors. Methods: Tumor tissue from 82
patients was fixed in formalin and embedded in paraffin blocks. These samples were analyzed by means of the streptavidin-biotin
immunohistochemical method, using the tissue microarray technique. Marker positivity was evaluated using categorical scores that
determined cutoff percentages of stained tumor cells. Protein tissue expression was correlated with the variables of degree of cell
differentiation, staging, disease-free interval, recurrence, survival and specific mortality. The Fisher exact and Kaplan-Meier tests were
used to assess associations between the markers and the study variables. The log-rank and Wilcoxon tests were used to assess the
significance of differences between curves of disease-free interval and survival. Results: All tumors were positive for metalloproteinase-1;
50 (61%) were positive and 32 (39%) were negative for metalloproteinase-7; and 60 (74.1%) were positive and 21 (25.9%) were
negative for VEGF. Correlation of marker expression, both in groups and individually, did not show statistical significance in relation
to the degree of cell differentiation, staging, disease-free interval, survival or specific mortality. Recurrence showed a statistically
significant correlation with positive expression of the three markers, when analyzed as a group (p = 0.038). Conclusion: The associated
expression of metalloproteinase-1, metalloproteinase-7 and VEGF in colorectal adenocarcinoma is related to the incidence of disease
recurrence.
Key words: Colorectal Neoplasms. Prognosis. Extracellular Matrix. Tumor Markers, Biological.
RESUMO
Objetivo: Analisar as expressões da metaloproteinase-1, metaloproteinase-7 e do fator de crescimento endotelial vascular no adenocarcinoma
colorretal e correlacionar com os fatores prognósticos clínico-patológicos. Métodos: Foram analisados tecidos fixados em formol e
dispostos em blocos de parafina dos tumores de 82 pacientes, por imunohistoquímica, pelo método da estreptavidina-biotina, usando-se
a técnica de arranjo em matriz de amostras teciduais (tissue microarray). Na avaliação da positividade dos marcadores foi utilizado um
escore categórico, que predeterminou o valor de corte na percentagem de células coradas do tumor. As expressões teciduais das proteínas
foram correlacionadas com as varáveis representadas pelo grau de diferenciação celular, estadiamento, tempo livre de doença, recidiva,
sobrevida e mortalidade específica. Foram empregados os testes exato de Fisher e de Kaplan-Meier para verificar as associações dos
marcadores com as varáveis estudadas. Para testar a significância das diferenças entre as curvas do tempo livre de doença e da sobrevida foram
utilizados os testes de longrank e Wilcoxon. Resultados: A metaloproteinase-1 foi positiva em todos os tumores. A metaloproteinase-7
foi positiva em 50 (61%) e negativa em 32 (39%) tumores. O fator de crescimento endotelial vascular foi positivo em 60 (74,1%) e
negativo em 21 (25,9%) tumores. A correlação das expressões dos marcadores realizada separadamente e em conjunto não apresentou
significância estatística com o grau de diferenciação celular, estadiamento, tempo livre de doença, sobrevida e mortalidade específica.
A recidiva apresentou correlação estatística significante com a expressão positiva dos três marcadores, quando foram analisados em
conjunto (p = 0,038). Conclusão: As expressões associadas da metaloproteinase-1, metaloproteinase-7 e do fator de crescimento endotelial
vascular no adenocarcinoma colorretal se relacionam com a incidência de recidiva da doença.
Descritores: Neoplasias Colorretais. Prognóstico. Matriz Extracelular. Marcadores Biológicos de Tumor.
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Introduction
The capacity of malignant cells to invade other tissues
and disseminate to distant organs is a characteristic that very often
leads to the host’s death. Proteolytic enzymes have a fundamental
role in cancer progression, through allowing tumor cells to access
the vascular and lymphatic systems that irrigate and sustain tumor
growth, thus creating routes for disease dissemination1,2. Among
the proteolytic enzymes associated with tumor invasion,
metalloproteinases have achieved considerable importance due to
their ability to cleave components of the extracellular matrix and
basal membranes. This allows penetration and infiltration of the
underlying stroma by neoplastic cells3.
Metalloproteinase-1 (MMP-1) is a collagenase that
degrades collagens I, II and III. Elevated expression of MMP-1
was associated with a poor prognosis in colorectal cancer cases4,5.
This was reaffirmed in another study in which MMP-1 was absent
from benign adenomas but presented elevated expression in
cases of invasive colorectal carcinomas. Furthermore, there were
correlations with the degree of invasion, lymph node involvement
and hepatic metastasis6.
Metalloproteinase-7 (MMP-7), named matrilysin, is
expressed in 90% of colonic adenocarcinomas7. The clinical
impact of its presence in colorectal cancer cases has been
evaluated, and increases in its expression have been associated
with the presence of lymph node and distant metastases8.
However, this enzyme seems to induce angiogenesis, thus
stimulating the proliferation of vascular endothelial cells and the
formation of new vessels adjacent to the colorectal tumor, which
facilitates metastatic dissemination9.
The formation of new blood vessels from preexisting
vessels, i.e. angiogenesis, is essential for the growth of solid
tumors larger than 1 or 2 mm³, in which the oxygen diffusion, per
se, does not attain sufficient distance to maintain an adequate level
in the tissue10. Angiogenesis is a complex process that depends on
the local balance between the proangiogenic and antiangiogenic
molecules that are released from neoplastic cells and also on the
host, including the immunological cells and adjacent stroma11. The
vascular endothelial growth factor (VEGF), basic fibroblastic
growth factor (bFGF), platelet-derived endothelial cell growth
factor (PD-ECGF), angiopoietins, thrombospondins and ephrins
are factors with angiogenic potential12.
The two initial events of great importance in metastasis
formation are the tumor cell proliferation and the creation of an
extensive network of vessels from preexisting vessels. Neoplastic
cells must invade the extracellular matrix and penetrate into the
blood and lymph vessels. The invasion process is helped by
decreased cell adhesion, increased cell mobility and secretion of
enzymes that degrade the extracellular matrix, such as
metalloproteinases, cathepsins and plasminogen activators13. High
VEGF expression in colorectal adenocarcinoma cases has been
associated with increased numbers of vessels in the invasive
margins of tumors and with cell proliferation and distant
metastases14. Another study found an inverse relationship between
VEGF expression and survival, thus confirming that invasive
colorectal cancer is dependent on angiogenesis15.
Clinical studies have suggested that elevated expression
of proteins relating to the cell cycle, angiogenesis and cell
invasion-migration may have prognostic significance for colorectal
adenocarcinoma cases. Therefore, the presence of markers in
tumors that are studied needs to be correlated with the
clinical-pathological characteristics, to enable identification of
tumor groups with specific phenotypes and similar clinical
results, so that they can be considered to have prognostic value16.
The present study analyzed the immunohistochemical
expressions of MMP-1, MMP-7 and VEGF in colorectal
adenocarcinoma cases and determined the correlations between
this group of tumor markers and the clinical-pathological
prognostic factors.
Methods
The analysis included 82 patients who underwent
surgical resection of colorectal adenocarcinoma at Hospital Sao
Paulo, between 2001 and 2005. This study had been granted prior
approval by the Research Ethics Committee of the Federal
University of São Paulo. Tumor samples were fixed in formalin
and processed routinely using the paraffin-embedding method.
Histological thin sections were stained using hematoxylin-eosin
and were reviewed by three pathologists to confirm the diagnosis.
Immunohistochemical analysis was performed on the samples by
means of the tissue microarray (TMA) technique. The international
classification for malignant tumors (TNM), as adopted by the
International Union against Cancer (UICC), was used for tumor
staging.
The study sample consisted of 44 females (53.7%) and 38
males (46.3%). The ages ranged from 29 to 89 years, with a mean
of 59 years. The follow-up ranged from six to 64 months, with a
mean of 35 months. Tumor location, urgency of the surgery,
degree of cell differentiation and staging are shown in Table 1.
Immunohistochemistry
The tumor samples were sliced into sections of 4 µm in
thickness, and the adhesive tape system (Instrumedics Inc.,
Hackensack, NJ, USA) was used to mount the slices on TMA blocks.
The paraffin was removed from the slides using xylol and alcohol.
Antigen recovery was performed for all the antibodies, except for
MMP-7. This process was carried out in a Pascal pressure chamber
in a citrate solution with pH 6 at 125ºC, lasting for 30 seconds after
reaching 125ºC and a pressure of between 20 and 25 psi. The sample
was then left to cool at room temperature for 20 minutes. After
washing in running water for 5 minutes, endogenous peroxidase
was blocked by means of 10 volumes of hydrogen peroxide for
5 minutes, followed by washing with PBS buffer at pH 7.4. A
protein blockade was performed using a protein blocker
(DaKoCytomation), with sample immersion for 20 minutes.
For the immunohistochemical reaction using the
streptavidin-biotin method, the following primary antibodies were
used: anti-VEGF monoclonal antibody (Clone VG-1)
(DaKoCytomation), diluted to 1:200; anti-MMP-1 polyclonal
antibody Ab-6 (NeoMarkers), diluted to 1:400; and anti-MMP-7
antibody Ab-1 (Clone ID2) (NeoMarkers), diluted to 1:1200. The
primary antibodies used for metalloproteinase identification
recognize both the active and the latent types. For the
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TABLE 1 – Clinical-pathological characteristics of the tumors
TUMOR CHARACTERISTICS  N PERCENTAGE 
R Colon  35 42. 7 
L Colon 19 23. 2 
Rectum 26 31. 7 
Tumor location 
Synchronic 2 2. 4 
Elective 67 81. 7 
Urgency of surgery 
Emergency 15 18. 3 
Low degree 78  95. 1 
Degree of differentiation 
High degree 4  4. 9 
I 10 12. 2 
II 32 39. 0 
III 26  31. 7 
Staging 
IV 14 17. 1 
R - Right  L – Left  
amplification system, NovoLink polymer (Novocastra) was used,
with a 30-minute incubation period, followed by washing with PBS
buffer. The reaction was developed performed using the 3,3
diaminobenzidine chromogen (Liquid DAB + Substrate Chromogen
System Kit, DaKoCytomation, Carpinteria, California), for 5
minutes, followed by washing in running water. The slide was
counterstained with Harris hematoxylin for 2 minutes and washed
in running water for 5 minutes. It was then dehydrated with
alcohol and washed with xylol, for subsequent mounting of cover
slips using Entellan resin (Sigma).
The positive pattern for primary antibodies is the
appearance of a chestnut-brown color in the cell cytoplasm. Slides
containing histological sections that had previously been shown to
be positive were used as positive controls, and slides with primary
antibody subtraction during an immunochemical reaction were used
as negative controls.
The criteria used for evaluating the MMP-1, MMP-7 and
VEGF markers were based on the use of categorical scores that
determined cutoff percentages of stained tumor cells Cases with
values greater than 10% were considered positive, while those
with values less than 10% were considered negative. The three
evaluators read the slides independently and did not have access
to the clinical data on the patients.
Statistical analyses
The Fisher exact test was used to analyze the tissue
expression of tumor markers in relation to separate and grouped
associations with the variables of degree of cell differentiation,
staging, recurrence and specific death.
The Kaplan-Meier life table method was used to compare
the tissue expression of tumor markers in relation to separate and
grouped associations with disease-free interval and survival. The
log-rank and Wilcoxon (Breslow version) tests were used to assess
the significance of any differences in the curves for disease-free
interval and survival. For the analyses performed, the limit of
p < 0.05 was established for rejection of the null hypothesis, and
the values considered to be statistically significant were highlighted.
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Results
The TMA block presented the loss of a few tissue samples.
The marker expression analysis showed that all the tumors were
positive for metalloproteinase-1; 50 tumors (61%) were positive
and 32 (39%) were negative for metalloproteinase-7; and 60
tumors (74.1%) were positive and 21 (25.9%) were negative for
VEGF (Figure 1).
The degree of cell differentiation did not show any
correlation with the expressions of MMP-1, MMP-7 (p = 0.16) or
VEGF (p = 0.7), or with the three markers together (p = 0.32).
Staging did not show any correlation with the expressions of
MMP-1, MMP-7 (p = 0.72) or VEGF (p = 0.78), or with the three
markers together (p = 0.66). Disease-free interval did not show
any correlation with the expressions of MMP-1, MMP-7 (p = 0.068)
or VEGF (p = 0.128), or with the three markers together (p = 0.089).
Disease recurrence did not show any correlation with the
expressions of MMP-1, MMP-7 (p = 0.83) or VEGF (p = 0.32),
but the three markers in association showed a statistically
significant difference (p = 0.038*) with this variable (Table 2).
Survival did not show any correlation with the expressions of
MMP-1, MMP-7 (p = 0.628) or VEGF (p = 0.561), or with the
three markers together (p = 0.503). Specific mortality did not show
any correlation with the expressions of MMP-1, MMP-7 (p = 0.43)
or VEGF (p = 0.4), or with the three markers together (p = 0.43).
The overall results from this investigation are shown in Table 3.
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Discussion
Prognostic markers are variable that provide prospective
information regarding patient success, i.e. they complement the
staging data obtained by pathologists and may guide therapeutic
decisions17. At present, histopathological confirmation of adequate
excision and tumor staging, which assess tumor invasion into
the intestinal wall and the presence of metastases to the lymph
nodes, are the basic staging methods used for prognostic
guidance. However, it is widely recognized that tumors of the same
pathological stage may produce considerably different clinical
results and, consequently, it is necessary to identify other factors
that influence prognosis, independent of tumor staging16.
The proteins investigated in this study are markers for cell
invasion-migration and for angiogenesis, and they have important
roles in the gradual development of the tumor. Previous reports
had suggested that these proteins could be used as prognostic
markers for colorectal cancer. The analysis on this group of
markers has determined that these molecules have reciprocal
action and shown their prognostic relevance. Metalloproteinases
are crucial for angiogenesis, since they degrade the extracellular
matrix, thus creating space for endothelial cell migration. On the
other hand, they release growth factors, among them VEGF, which
are linked to the extracellular matrix, and these recruit pericytes
from the preexisting vessels in order to create new blood vessels
that will be responsible for the growth of the neoplasm and for
metastatic dissemination18.
The initial event in colorectal carcinogenesis is the
mutation of the suppressor gene APC, in up to 80% of human
tumors. This event leads to the loss of gene function and
subsequent decreased production of the APC protein, which is
responsible for degradation of ß-catenin. Accumulation of this
protein in the cytoplasm and nucleus of the cell, through the WNT
signaling pathway, starts the nuclear transcriptional activity,
thereby resulting in the expression of target genes, such as those
for MMP-7. This phenomenon has been observed in cell cultures
from human colorectal adenocarcinoma, and it could explain the
increased expression of MMP-7 in colorectal cancer19.
MMP-7 seems to influence cell migration in colonic
carcinoma through the cleavage of the ß3 chain of laminin-5, an
important component of the epithelial basal membrane, thus
reinforcing the role of metalloproteinases in tumor progression20.
On the other hand, an experimental investigation has associated
MMP-7 with angiogenesis, through the observation that new blood
vessels were produced adjacent to cell cultures of human colon
adenocarcinoma, with increased expression of MMP-7, when the
cells were implanted in the dorsum of mice. In animals with cell
implants that were treated with a specific MMP-7 blocker, there
was no induction of blood vessel formation9.
TABLE 3 – Distribution of results for tumor expression of MMP-1, MMP-7 and VEGF in relation to the clinical and pathological variables analyzed
P = positive  N = negative
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Recurrence        0.83    0.32    0.038* 
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The capacity of a tumor to invade the intestinal wall and
produce metastases depends on angiogenesis. This gives rise to an
extensive network of capillary vessels to provide nutrition for the
neoplasm and creates the conditions for cancer cells to enter the
bloodstream and form secondary foci in distant organs21. Analysis
of VEGF RNAm expression in colorectal cancer and its
relationship with clinical characteristics has shown that increased
expression of VEGF RNAm in the tumor presents a significant
correlation with the degree of invasion depth in the intestinal wall,
and with distant and lymph node metastases22.
MMP-1 has a key role in the lysis of collagens I and III,
which are the main components of the gastrointestinal tract stroma.
Cleavage of these structural components allows invasion of
neoplastic cells into the intestinal wall. This MMP-1 activity is
more intense in the initial stages of local tumor invasion. Increased
MMP-1 expression has shown a statistically significant correlation
with the presence of involved lymph nodes at the time of diagnosis
and metachronic metastases, thus suggesting that this enzyme
participates in the dissemination of colorectal cancer23. In the
present study, when the positive expression of this proteinase
was analyzed separately, there was no association between it and
the previously mentioned variables.
In the present study, the immunohistochemical
expressions of MMP-1, MMP-7 and VEGF were analyzed in
colorectal tumors, and the results obtained were further correlated
with the main clinical-pathological prognostic factors, i.e. the
degree of cell differentiation, staging, disease-free interval,
recurrence, survival and specific mortality. None of these factors
was shown to be separately or jointly associated with the markers,
except for recurrence. When all three markers were analyzed
together, positive expression of these markers showed a statistically
significant correlation with recurrence, in comparison with
negative expression, thus suggesting that there is a molecular
profile relating to disease prognosis.
With regard to the degree of cell differentiation, the present
study did not show any association with MMP-1 expression. This
result was similar to findings by some other authors24. On the other
hand, this association was shown to be statistically significant in
another investigation25. MMP-7 did not show any correlation in
this respect, like in other reports26,27,28. VEGF did not correlate with
this variable, and this finding is corroborated by another study29,
although there was a statistically significant association with the
degree of tumor differentiation in stage II (TNM) in the study by
Cascinu et al.30 and in undifferentiated neoplasms in another report31.
When the marker expression was correlated with staging,
there was no association with MMP-1. This was also observed in
the study by Sunami et al.32, who used the Dukes classification. On
the other hand, other authors who used the same staging method as
in the present study found statistically significant correlations4,6,25.
MMP-7 was not associated with staging in the present study, and a
similar result was found in the study by Schwandner et al.28, who
used the TNM classification. However, increased expression of this
enzyme showed correlations with disease staging in other studies
that used the Dukes classification8,27. There was no correlation
between VEGF and staging in the present study, and this result was
compatible with what was observed by Shu et al.31, who also used
the TNM staging method. However, Nakasaki et al.29 found a
statistically significant correlation between the expression of this
protein and the Dukes classification.
MMP-1 expression in tumors did not show any
statistically significant correlation with disease-free interval in the
present study, and this was similar to the result presented by
Bendardaf et al.23. However, the expression of this enzyme was
positive in all tumors in another report, in which the patients were
divided into two groups named low expression and high
expression. Disease-free survival in that study was significantly
higher among individuals who presented low MMP-1 expression,
in comparison with those who had high expression32. MMP-7
expression in tumors in the present investigation was not associated
with this clinical characteristic, and the literature consulted did not
present data on this variable. VEGF expression in tumors in the
present study did not correlate with disease-free survival, and this
finding is corroborated in the report by Kekec et al.33. However, a
meta-analysis carried out by Des Guetz et al.15 found a statistically
significant correlation between positive expression of VEGF and
decreased disease-free interval, thus reinforcing the importance of
this growth factor for disease progression.
When analyzing the association of MMP-1 and MMP-7
expression with recurrence, the present study did not show any
statistical significance, and this result was similar to that of other
studies24,26. In the present study, VEGF expression did not show
correlation any with this variable, in the same way as found in the
analysis carried out by Kekec et al.33. On the other hand, many
authors have reported a strong correlation between positive
expression of VEGF and disease recurrence, thereby classifying
patients with such characteristics as presenting a high risk of
disease recurrence30,34,35. Nonetheless, when the three markers were
assessed as a group for correlation with disease recurrence, the
result found in the present study was statistically significant, thus
suggesting that the presence of this set of markers increases the
risk of tumor recurrence.
In the present study, MMP-1, MMP-7 and VEGF
expression did not show any statistically significant correlations
with survival when analyzed either separately or as a group.
Bendardaf et al.23 found a similar result when analyzing MMP-1
expression in colorectal tumors, and this a finding has been
corroborated by other two studies that used larger groups of
markers, among which MMP-1 and MMP-716,24. However,
Murray et al.4 observed statistical significance between high
MMP-1 expression in tumors and survival. Regarding VEGF, the
results obtained in the present study are different from those of
other researchers who studied this variable, since they reported
that increased expression of this marker was strongly associated
with decreased survival33,35. Reinforcing this hypothesis, a
meta-analysis concluded that VEGF expression had an inverse,
statistically significance relationship with survival15.
In the present sample, 16 individuals died as a result of
the disease, but the markers did not present a statistically
significant correlation with specific mortality, either separately or
as a group. No reports in the literature consulted used this variable
as a prognostic indicator in analyzing correlations with MMP-1,
MMP-7 and VEGF expression in colorectal tumors.
Several prognostic markers for colorectal cancer have been
described in immunohistochemical investigations that analyzed
single or small groups of molecules, which are the correct manner
to proceed for the initial evaluation of possible markers. The
results obtained were conflicting, since the studies were carried
out among populations with small numbers of individuals,
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including all disease stages, with inadequate follow-up duration
and within a restricted biological context. The inclusion of all
disease stages makes the analysis inappropriate for answering
this question and dilutes the statistical power of the study. Stage I
has little potential for clinical applicability and stage IV is associated
with the tumor response to therapy, or is applicable for observing
the quality of life among these patients. To evaluate the clinical
usefulness of a marker, it is necessary to assess a large number of
well-characterized patients, belonging to a specific disease stage,
and over a long follow-up period. Thus, if there is a clear association
between the factor and the clinical outcomes under observation,
the study will provide a trustworthy result, with high statistical
power17.
The present study analyzed three molecular markers within
two biological contexts and found an association between the
immunohistochemical expressions of MMP-1, MMP-7 and VEGF
in colorectal adenocarcinoma and disease recurrence. However,
other studies need to be devised in order to prove the consistency
of this association, using a well-defined group of individuals, with
a larger number of markers that are involved in a wide variety of
biological functions, and with a higher statistical power.
Therefore, the results from the present study and the findings in
the literature make it possible to conclude that, so far, there is
insufficient evidence to justify the use of the tumor expression of
these molecular markers in clinical practice.
Conclusion
The associated expression of metalloproteinase-1,
metalloproteinase-7 and VEGF in colorectal adenocarcinoma is
related to the incidence of disease recurrence.
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